1. Academic Validation
  2. ApoE2, ApoE3, and ApoE4 Differentially Stimulate APP Transcription and Aβ Secretion

ApoE2, ApoE3, and ApoE4 Differentially Stimulate APP Transcription and Aβ Secretion

  • Cell. 2017 Jan 26;168(3):427-441.e21. doi: 10.1016/j.cell.2016.12.044.
Yu-Wen Alvin Huang 1 Bo Zhou 2 Marius Wernig 3 Thomas C Südhof 4
Affiliations

Affiliations

  • 1 Department of Molecular and Cellular Physiology and Howard Hughes Medical Institute, Stanford University Medical School, Stanford, CA 94305, USA.
  • 2 Department of Molecular and Cellular Physiology and Howard Hughes Medical Institute, Stanford University Medical School, Stanford, CA 94305, USA; Institute for Stem Cell Biology and Regenerative Medicine and Department of Pathology, Stanford University Medical School, Stanford, CA 94305, USA.
  • 3 Institute for Stem Cell Biology and Regenerative Medicine and Department of Pathology, Stanford University Medical School, Stanford, CA 94305, USA.
  • 4 Department of Molecular and Cellular Physiology and Howard Hughes Medical Institute, Stanford University Medical School, Stanford, CA 94305, USA. Electronic address: tcs1@stanford.edu.
Abstract

Human Apolipoprotein E (apoE) Apolipoprotein is primarily expressed in three isoforms (ApoE2, ApoE3, and ApoE4) that differ only by two residues. ApoE4 constitutes the most important genetic risk factor for Alzheimer's disease (AD), ApoE3 is neutral, and ApoE2 is protective. How apoE isoforms influence AD pathogenesis, however, remains unclear. Using ES-cell-derived human neurons, we show that apoE secreted by glia stimulates neuronal Aβ production with an ApoE4 > ApoE3 > ApoE2 potency rank order. We demonstrate that apoE binding to apoE receptors activates dual leucine-zipper kinase (DLK), a MAP-kinase kinase kinase that then activates MKK7 and ERK1/2 MAP kinases. Activated ERK1/2 induces cFos phosphorylation, stimulating the transcription factor AP-1, which in turn enhances transcription of Amyloid-β precursor protein (APP) and thereby increases Amyloid-β levels. This molecular mechanism also regulates APP transcription in mice in vivo. Our data describe a novel signal transduction pathway in neurons whereby apoE activates a non-canonical MAP kinase cascade that enhances APP transcription and Amyloid-β synthesis.

Keywords

APP; Alzheimer’s disease; ApoE; Aβ; CRISPR; CRISPRi; DLK; MAP kinase signaling; amyloid precursor protein; apolipoprotein E; beta amyloid; cFos; dual leucine-zipper kinase; transcription.

Figures
Products